Clients are encouraged to ask any questions they may have, big or small
For pharmaceutical companies, the growing trend of off-label prescribing presents both opportunities and challenges
Electrolyte monitoring is not routinely required for all GLP-1 users, but becomes essential when patients experience persistent gastrointestinal symptoms or have additional risk factors such as chronic kidney disease, heart failure, age over 65, or concurrent diuretic use
These trends may have long-term implications for many companies, particularly in the Food & Beverage (F&B) industry
Thanks to Glen and the whole staff at Affinity Whole Health
Behavioral Support Behavioral interventions, such as cognitive-behavioral therapy (CBT) or family-based approaches, can be beneficial in addressing the psychological aspects of obesity